Upstream / Downstream

Explore pathways related to this product.

Our U.S. Offices Are Closed

Our U.S. offices are closed in observance of Thanksgiving. We will reopen on Monday, December 1st.

Thank you for your patience.

To Purchase # 8918SC

8918SC 10 µg (With Carrier) $199.00
8918SF 10 µg (Carrier Free) $199.00
8918LC 50 µg (With Carrier) $599.00
8918LF 50 µg (Carrier Free) $599.00
$ 0. 00

Questions?

Find answers on our FAQs page.

ANSWERS  

Visit PhosphoSitePlus®

PTM information and tools available.

LEARN MORE

Source / Purification

Recombinant human interleukin-3 (hIL-3) Ala20-Phe152 (Accession # NP_000579) was expressed in human 293 cells at Cell Signaling Technology.

Product Description

Purity:

>98% as determined by SDS-PAGE of 6 μg reduced (+) and non-reduced (-) recombinant hIL-3. All lots are greater than 98% pure.


Molecular Formula:

Recombinant hIL-3 contains no "tags" and the nonglycosylated protein has a calculated MW of 15,091. DTT-reduced and non-reduced protein migrate as 26 kDa polypeptides. Lower mobility and heterogeneity in SDS PAGE are due to glycosylation. The expected amino-terminal APMTQ of recombinant hIL-3 was verified by amino acid sequencing.


Bioactivity:

The bioactivity of recombinant hIL-3 was determined in a TF-1 cell proliferation assay. The ED50 of each lot is between 50 -400 pg/ml.


Endotoxin:

Less than 0.01 ng endotoxin/1 μg hIL-3.


Product Usage Information

Formulation:

With carrier: Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.2 containing 20 μg BSA per 1 μg hIL-3. Carrier free: Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.2.


Storage: Stable in lyophilized state at 4°C for 1 year after receipt. Sterile stock solutions reconstituted with carrier protein are stable at 4°C for 2 months and at -20°C for 6 months. Avoid repeated freeze-thaw cycles.Maintain sterility. Storage at -20°C should be in a manual defrost freezer.

IL-3 is produced by T cells, mast cells and eosinophils (1). Target cells include hematopoietic progenitors, neutrophils, macrophages, mast cells, eosinophils, lymphoid and erythroid cells (1). The IL-3 receptor is a heterodimer of the IL-3 specific α-chain and the common β-chain, βc, which is also used by GM-CSF and IL-5. (1). Binding of IL-3 can also involve substitution of the βc by a βIL-3-chain that appears to be specific for IL-3 (1,2). Binding of IL-3 to its cognate receptor(s) induces activation of Jak2, phosphorylation of multiple Stats (1,3,5,6), and the PI3K/Akt pathway (1). IL-3 may play an important role in the development of airway inflammation associated with asthma (3,4,5).


1.  Reddy, E.P. et al. (2000) Oncogene 19, 2532-47.

2.  Hara, T. and Miyajima, A. (1992) EMBO J 11, 1875-84.

3.  Asquith, K.L. et al. (2008) J Immunol 180, 1199-206.

4.  Schroeder, J.T. et al. (2009) J Immunol 182, 2432-8.

5.  Munitz, A. et al. (2006) J Immunol 177, 77-83.


Entrez-Gene Id 3562
Swiss-Prot Acc. P08700


For Research Use Only. Not For Use In Diagnostic Procedures.
Cell Signaling Technology® is a trademark of Cell Signaling Technology, Inc.